Matches in SemOpenAlex for { <https://semopenalex.org/work/W2233025574> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- W2233025574 endingPage "400" @default.
- W2233025574 startingPage "393" @default.
- W2233025574 abstract "Ninety-five hypertensive outpatients of both sexes, aged 23 to 65 years with diastolic blood pressures above 105 but below 120 mmHg (greater than 14.0 but less than 16.0 kPa), after one week on a placebo were randomly assigned either to nicardipine plus a placebo (40 mg/day - 48 patients) or nifedipine sustained-release plus a placebo (20 mg/day - 47 patients) for an additional six weeks. The study groups were homogeneous and comparable. After the run-in period the average blood pressure was 181 +/- 17/116 +/- 9 mmHg (24.1 +/- 2.3/15.5 +/- 1.2 kPa) in the nicardipine and 177 +/- 22/116 +/- 9 mmHg (23.6 +/- 2.9/15.5 +/- 1.2 kPa) in the nifedipine group (p greater than 0.10). In the acute oral test (nicardipine 40 mg to all the subjects; blood pressure measured at 30 min intervals during two hours) almost identical hypotensive effects within and between groups were observed (mean arterial pressure decrease of 11%, after 120 min; p less than 0.05). At the end of this trial blood pressure decreased further to 152 +/- 12/94 +/- 11 mgHg (20.3 +/- 1.6/12.5 +/- 1.5 kPa) (mean decrease of 20%; p less than 0.01) on nicardipine and to 145 +/- 12/94 +/- 11 mmHg (19.3 +/- 1.6/12.5 +/- 1.5 kPa) (mean decrease of 20%; p less than 0.01) on nifedipine. There were no significant changes in pulse rate. The observed between-group differences were trivial (p greater than 0.10). The laboratory data did not alter appreciably during this study. Three patients on nicardipine and four on nifedipine reported headache, palpitations and flushing: one patient on nicardipine and two on nifedipine were as a result excluded from the trial. It was concluded that nicardipine and nifedipine sustained-release were comparably effective and well-tolerated drugs suitable as the first-line agents for the management of mild to moderate hypertension." @default.
- W2233025574 created "2016-06-24" @default.
- W2233025574 creator A5009895943 @default.
- W2233025574 creator A5015398638 @default.
- W2233025574 creator A5015941583 @default.
- W2233025574 creator A5040227175 @default.
- W2233025574 creator A5041247322 @default.
- W2233025574 creator A5041855873 @default.
- W2233025574 creator A5047898980 @default.
- W2233025574 creator A5058189813 @default.
- W2233025574 creator A5087484631 @default.
- W2233025574 date "1988-01-01" @default.
- W2233025574 modified "2023-10-17" @default.
- W2233025574 title "Nicardipine versus nifedipine: multicentre controlled trial in essential hypertension." @default.
- W2233025574 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/3075601" @default.
- W2233025574 hasPublicationYear "1988" @default.
- W2233025574 type Work @default.
- W2233025574 sameAs 2233025574 @default.
- W2233025574 citedByCount "2" @default.
- W2233025574 crossrefType "journal-article" @default.
- W2233025574 hasAuthorship W2233025574A5009895943 @default.
- W2233025574 hasAuthorship W2233025574A5015398638 @default.
- W2233025574 hasAuthorship W2233025574A5015941583 @default.
- W2233025574 hasAuthorship W2233025574A5040227175 @default.
- W2233025574 hasAuthorship W2233025574A5041247322 @default.
- W2233025574 hasAuthorship W2233025574A5041855873 @default.
- W2233025574 hasAuthorship W2233025574A5047898980 @default.
- W2233025574 hasAuthorship W2233025574A5058189813 @default.
- W2233025574 hasAuthorship W2233025574A5087484631 @default.
- W2233025574 hasConcept C126322002 @default.
- W2233025574 hasConcept C142724271 @default.
- W2233025574 hasConcept C204787440 @default.
- W2233025574 hasConcept C27081682 @default.
- W2233025574 hasConcept C2776452961 @default.
- W2233025574 hasConcept C2777097880 @default.
- W2233025574 hasConcept C2777953023 @default.
- W2233025574 hasConcept C2778043224 @default.
- W2233025574 hasConcept C2779066535 @default.
- W2233025574 hasConcept C2992203999 @default.
- W2233025574 hasConcept C42219234 @default.
- W2233025574 hasConcept C519063684 @default.
- W2233025574 hasConcept C71924100 @default.
- W2233025574 hasConcept C84393581 @default.
- W2233025574 hasConceptScore W2233025574C126322002 @default.
- W2233025574 hasConceptScore W2233025574C142724271 @default.
- W2233025574 hasConceptScore W2233025574C204787440 @default.
- W2233025574 hasConceptScore W2233025574C27081682 @default.
- W2233025574 hasConceptScore W2233025574C2776452961 @default.
- W2233025574 hasConceptScore W2233025574C2777097880 @default.
- W2233025574 hasConceptScore W2233025574C2777953023 @default.
- W2233025574 hasConceptScore W2233025574C2778043224 @default.
- W2233025574 hasConceptScore W2233025574C2779066535 @default.
- W2233025574 hasConceptScore W2233025574C2992203999 @default.
- W2233025574 hasConceptScore W2233025574C42219234 @default.
- W2233025574 hasConceptScore W2233025574C519063684 @default.
- W2233025574 hasConceptScore W2233025574C71924100 @default.
- W2233025574 hasConceptScore W2233025574C84393581 @default.
- W2233025574 hasIssue "6" @default.
- W2233025574 hasLocation W22330255741 @default.
- W2233025574 hasOpenAccess W2233025574 @default.
- W2233025574 hasPrimaryLocation W22330255741 @default.
- W2233025574 hasRelatedWork W1971660353 @default.
- W2233025574 hasRelatedWork W1989455164 @default.
- W2233025574 hasRelatedWork W2006070965 @default.
- W2233025574 hasRelatedWork W2008078773 @default.
- W2233025574 hasRelatedWork W205816682 @default.
- W2233025574 hasRelatedWork W2233025574 @default.
- W2233025574 hasRelatedWork W2280374491 @default.
- W2233025574 hasRelatedWork W2367019110 @default.
- W2233025574 hasRelatedWork W2396627535 @default.
- W2233025574 hasRelatedWork W2419116727 @default.
- W2233025574 hasVolume "8" @default.
- W2233025574 isParatext "false" @default.
- W2233025574 isRetracted "false" @default.
- W2233025574 magId "2233025574" @default.
- W2233025574 workType "article" @default.